idmi

Astronics Corporation (Nasdaq: ATRO) 30% LOWER; reports Q4 EPS of $0.24, versus the consensus of $0.31. Revenues came in at $36.3 million, versus the consensus of $35.05 million.

Sees 2008 revenues of $170 million, versus the consensus of $186.6 million. IDM Pharma (Nasdaq: IDMI) 28.4% HIGHER; continues to see high volume and volatility today, extending a trade trend that has played out over February.

Last week, on Monday, the stock opened at $0.79, rose to $3.81 on Tuesday, and closed the week on Friday at $1.68.

Multi FineLine Electronix Inc. (Nasdaq: MFLX) 40% HIGHER; reports Q1 EPS of $0.54, 40 cents better than the analyst estimate of $0.14.

Revenues for the quarter were $184.1 million, versus the consensus of $175.26 million. IDM Pharma (Nasdaq: IDMI) 33.3% LOWER; at the close on Friday of last week, IDM's stock was trading around $0.80.

Yesterday, the stock closed at $3.81. A run-up of 382% is obviously unsustainable and even today's 30% pullback still puts the stock up about 350% on the week.

IDM Pharma (Nasdaq: IDMI) 72.8% HIGHER; rose by 40% yesterday after the Company announced that a late-stage clinical trial for its rare bone cancer drug returned positive results and reduced the risk of death by 30%.

Today, shares of IDM continue to show strong momentum as the shares are surging even more than yesterday when the news was released.

SiRF Technology Holdings Inc. (Nasdaq: SIRF) 52% LOWER; reports Q4 EPS of $0.28, 4 cents lower than the analyst estimate of $0.32.

Revenues for the quarter were $100.4 million, versus the consensus of $100.99 million. Rainmaker Systems, Inc.